Weighing The Suitability Of A FSP Model For Clinical Trials

At every step on the clinical development pathway, clinical and regulatory teams are faced with increased pressure to drive uninterrupted progress. To minimize the risk of failure and missed milestones, these teams turn to an external partner for support. Noted to be a routine benefit, a good partner will also offer supplemental expertise to improve the likelihood of commercial success.

However, given the number of options, deciding on the right partner to augment internal resources and advance a clinical trial successfully can be challenging. Trial sponsors may seek out a service provider with the capabilities to handle all aspects of the study from end-to-end, to look for a specific service capability, or may choose to tap individual experts or a team of experts and bring them in-house. The decision really comes down to defining/refining the study’s needs and finding a proven partner who can adapt and flex to its unique requirements.

Consider these key points when deciding if a functional service approach could better serve a clinical team and their study.